
Opinion|Videos|August 9, 2024
Comparing and Contrasting the Characteristics of the FDA-Approved Pneumococcal Vaccines
The pneumococcal vaccination experts offer a comparative analysis of the five FDA-approved pneumococcal vaccines, focusing on their structural differences and the specific strains each vaccine targets.
Advertisement
Episodes in this series

- Please compare the 5 currently FDA-approved pneumococcal vaccines with regards to vaccine structure and how the strains they target differ.
- How is the structure of covalent different from the structure of conjugate products.
- How is the structure of covalent different from the structure of conjugate products.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
3
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
4
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
5
















































































































































































































